Looking for a CFO? Learn more here!
All posts

UBS Obtains US Banking Licence To Expand Wealth Management

UBS obtained a U.S. national bank charter to expand wealth-management services including deposits and mortgages.
UBS Obtains US Banking Licence To Expand Wealth Management
Copy link

ZURICH, March 20 (Reuters)UBS has successfully secured a national banking license in the United States, marking a key step in the Swiss bank’s efforts to expand and strengthen its wealth management capabilities in the world’s largest economy. The approval was granted by the Office of the Comptroller of the Currency, as confirmed by UBS on Friday.

"This will strengthen our momentum in the U.S. and it reinforces our ambition to lead as a premier global wealth manager", said Rob Karofsky, President of UBS Americas, in a video statement shared via LinkedIn.

Unlocking New Opportunities in Everyday Banking

The bank’s achievement follows its application to convert its U.S. subsidiary, UBS Bank USA, into a nationally chartered bank. This pivotal move allows UBS to broaden its service offerings to include products such as checking accounts, savings accounts, and mortgages, placing it on a more level playing field with domestic U.S. lenders.

Brian Carlin, UBS’s head of global wealth management U.S., highlighted the significance of this milestone. "We’re now going to go head-to-head with offering everyday banking", he said. However, Carlin cautioned that building up the new services and client base would require time. According to an unnamed source familiar with the matter, these new banking products are expected to become available toward the end of 2027.

U.S. Market: A Crucial Growth Frontier

UBS’s ambitions in the U.S. market are underpinned by its status as a critical growth area for wealth management. The bank is capitalizing on a growing pool of high-net-worth individuals, with more than 1,000 people becoming millionaires in the U.S. each day as of 2024.

Despite its significant presence, UBS faces stiff competition, particularly from U.S.-based financial powerhouses like Morgan Stanley, which maintain higher profitability. Analysts and industry sources have noted that UBS has faced challenges in revamping its U.S. business, including the loss of billions of dollars in client assets and nearly 200 financial advisers.

Strategic Moves Amid Regulatory Challenges

The decision to deepen its foothold in the U.S. comes amid tightening banking regulations in Switzerland. Since UBS acquired its troubled rival Credit Suisse in 2023, the Swiss government has taken steps to make the banking sector less risky, proposing stricter regulations. UBS has been critical of these measures, arguing that they impose excessive capital requirements, potentially putting the bank at a competitive disadvantage.

As UBS works to meet investor expectations for higher returns, the U.S. expansion offers a promising avenue for growth. The bank’s new national license marks a significant step forward in its strategy to compete more effectively and offer a wider range of services in a competitive market.

Read the source

Founder to Freedom Weekly
Zero guru BS. Real founders, real exits, real strategies - delivered weekly.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our blog

Founders' Playbook: Build, Scale, Exit

We've built and sold companies (and made plenty of mistakes along the way). Here's everything we wish we knew from day one.
Dynamic Capital Allocation for Startup Growth
3 min read

Dynamic Capital Allocation for Startup Growth

Treat capital as a fluid resource—use KPI-driven, AI-enabled reallocations and flexible frameworks to scale startups faster and reduce cash-flow risk.
Read post
Healthcare M&A: Culture Integration Challenges
3 min read

Healthcare M&A: Culture Integration Challenges

How cultural clashes derail healthcare mergers and how to assess, communicate, align leadership, and measure integration.
Read post
FP&A Tips for Biotech Startups Raising Capital
3 min read

FP&A Tips for Biotech Startups Raising Capital

Practical FP&A guidance for biotech startups: milestones, runway models, dilution control, investor-ready financials.
Read post
Business Valuation Calculator
3 min read

Business Valuation Calculator

Estimate your company’s value using revenue, profit, and EBITDA multiples, with debt and cash adjustments for a clearer picture.
Read post

Get the systems and clarity to build something bigger - your legacy, your way, with the freedom to enjoy it.